NCT04414423

Brief Summary

The aim of this study will be to analyze the newly formed bone volume and density, 6 months after alveolar cleft grafting using iliac cancellous bone graft, with and without bone marrow concentrate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

December 7, 2021

Status Verified

December 1, 2021

Enrollment Period

1.1 years

First QC Date

May 25, 2020

Last Update Submit

December 5, 2021

Conditions

Keywords

bone marrow concentratealveolar cleftCBCTBone densitybone volume

Outcome Measures

Primary Outcomes (1)

  • bone volume

    V= (A1xT) + ( A2 xT) + …….+ (An xT) where: V= volume A= area T= thickness of the axial C.T slice N=number of slices

    six months postoperative

Secondary Outcomes (2)

  • bone density

    six months postoperative

  • bone formation ratio

    six months postoperative

Study Arms (2)

Bone marrow concentrate

EXPERIMENTAL

Bone marrow concentrate combined with Autogenous bone graft

Procedure: bone marrow concentrate alveolar cleft grafting

autogenous bone graft

ACTIVE COMPARATOR

grafting with autogenous bone graft

Procedure: Autogenous alveolar grafting

Interventions

patients will undergo surgery to repair alveolar cleft with autogenous bone graft combined with bone marrow concentrate

Bone marrow concentrate

patients will undergo surgery to repair alveolar cleft with autogenous bone graft

autogenous bone graft

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients suffering from maxillary alveolar cleft
  • Patient with Primary, complete cleft lip

You may not qualify if:

  • Syndromic cases will be excluded
  • Previous operated cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Dentistry

Al Fayyum, 63514, Egypt

Location

Faculty of Dentistry

Cairo, 21523, Egypt

Location

Related Publications (3)

  • Pinheiro FHSL, Drummond RJ, Frota CM, Bartzela TN, Dos Santos PB. Comparison of early and conventional autogenous secondary alveolar bone graft in children with cleft lip and palate: A systematic review. Orthod Craniofac Res. 2020 Nov;23(4):385-397. doi: 10.1111/ocr.12394. Epub 2020 Jun 28.

    PMID: 32446283BACKGROUND
  • Ziegler CG, Van Sloun R, Gonzalez S, Whitney KE, DePhillipo NN, Kennedy MI, Dornan GJ, Evans TA, Huard J, LaPrade RF. Characterization of Growth Factors, Cytokines, and Chemokines in Bone Marrow Concentrate and Platelet-Rich Plasma: A Prospective Analysis. Am J Sports Med. 2019 Jul;47(9):2174-2187. doi: 10.1177/0363546519832003. Epub 2019 Apr 29.

    PMID: 31034242BACKGROUND
  • Shabaan AA, Salahuddin A, Aboulmagd I, Ragab R, Salah KA, Rashid A, Ayad HM, El Aty Ahmed WA, Refahee SM. Alveolar cleft reconstruction using bone marrow aspirate concentrate and iliac cancellous bone: A 12-month randomized clinical study. Clin Oral Investig. 2023 Nov;27(11):6667-6675. doi: 10.1007/s00784-023-05276-9. Epub 2023 Oct 5.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eighteen patients will be divided into two equal groups. Each group comprises nine patients.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor in oral & maxillofacial Surgery Department

Study Record Dates

First Submitted

May 25, 2020

First Posted

June 4, 2020

Study Start

November 1, 2020

Primary Completion

November 20, 2021

Study Completion

December 1, 2021

Last Updated

December 7, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations